BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8862271)

  • 21. Cellular immune responses of healthy and Mycobacterium leprae-inoculated armadillos (Dasypus novemcinctus).
    Rivero-Nava L; Quesada-Pascual F; Estrada-Garcia I; Estrada-Parra S; Santos-Argumedo L
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):485-7. PubMed ID: 10347570
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological specificity of Mycobacterium tuberculosis glycolipids.
    Papa F; Laszlo A; David HL; Daffé M
    Acta Leprol; 1989; 7 Suppl 1():98-101. PubMed ID: 2504016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A spot test for detection of antibodies to phenolic glycolipid I.
    Young DB; Fohn MJ; Khanolkar SR; Buchanan TM
    Lepr Rev; 1985 Sep; 56(3):193-8. PubMed ID: 2414626
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment: the serodiagnosis of leprosy.
    González AB; González-Albreu E
    Lepr Rev; 1994 Jun; 65(2):147-9. PubMed ID: 7968190
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of the name Mycobacterium w for the leprosy immunotherapeutic bacillus creates confusion with M. tuberculosis-W (Beijing strain): a suggestion.
    Talwar GP; Ahmed N; Saini V
    Infect Genet Evol; 2008 Jan; 8(1):100-1. PubMed ID: 17766188
    [No Abstract]   [Full Text] [Related]  

  • 26. Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment.
    Rada E; Aranzazu N; Ulrich M; Convit J
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):414-21. PubMed ID: 10700916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to phenolic glycolipid-1 of Mycobacterium leprae in urine of leprosy patients.
    Patil SA; Katoch K; Singh KP; Ramu G; Sengupta U
    J Infect Dis; 1990 Jul; 162(1):281-2. PubMed ID: 2192009
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assay (ELISA) with mycobacterial crude antigens for the sero-epidemiological diagnosis of active tuberculosis.
    Escobar-Gutierrez A; Amezcua-Chavarria ME; Pasten-Sanchez S; Ramirez-Casanova E; Cazares JV; Granados G; Loo-Mendez E; Cicero R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):417-27. PubMed ID: 9030108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactivity of anti-10kD heat shock protein antibodies in leprosy and tuberculosis patients.
    Rojas RE; Demichelis SO; Giménez MF; Molinari ML; Segal-Eiras A
    Medicina (B Aires); 1997; 57(5):581-6. PubMed ID: 9674227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract]   [Full Text] [Related]  

  • 31. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
    Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy.
    Young DB; Harnisch JP; Knight J; Buchanan TM
    J Infect Dis; 1985 Nov; 152(5):1078-81. PubMed ID: 3900237
    [No Abstract]   [Full Text] [Related]  

  • 33. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA.
    Wu Q; Yin Y; Zhang L; Chen X; Yu Y; Li Z; Yu H; Lu C; Feng S; Li X; Huo W; Ye G
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):1-8. PubMed ID: 12120035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunology of a burnt-out lepromatous leprosy patient.
    Baliña LN; Jotimliansky L; Sasiain MC; Minnucci F; Kien MC; Chouela E
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):102-4. PubMed ID: 1602187
    [No Abstract]   [Full Text] [Related]  

  • 35. High anti-phenolic glycolipid-I IgM titers and hidden leprosy cases, Amazon region.
    Salgado CG; Ferreira DV; Frade MA; Guimarães Lde S; da Silva MB; Barreto JG
    Emerg Infect Dis; 2012 May; 18(5):889-90. PubMed ID: 22515845
    [No Abstract]   [Full Text] [Related]  

  • 36. Epitope mapping of twelve monoclonal antibodies against the phenolic glycolipid-I of M. leprae.
    Fujiwara T; Minagawa F; Sakamoto Y; Douglas JT
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):477-86. PubMed ID: 9465158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.
    Bothamley G; Beck JS; Britton W; Elsaghier A; Ivanyi J
    Clin Exp Immunol; 1991 Dec; 86(3):426-32. PubMed ID: 1721012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
    Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL).
    Rada EM; Zambrano EA; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):222-5. PubMed ID: 16830648
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.